From Amgen to Gilead, drugmakers are sitting on billions of cash — and top pharma executives are hinting about big M&A to come in 2019

Canada News News

From Amgen to Gilead, drugmakers are sitting on billions of cash — and top pharma executives are hinting about big M&A to come in 2019
Canada Latest News,Canada Headlines
  • 📰 BusinessInsider
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 51%

Billion-dollar deals from drug giants Eli Lilly & Co. and Bristol-Myers Squibb could set the tone for a year full of healthcare acquisitions.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

BusinessInsider /  🏆 729. in US

Canada Latest News, Canada Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

U.S. top court rejects Amgen over cholesterol medication patent fightU.S. top court rejects Amgen over cholesterol medication patent fightThe U.S. Supreme Court on Monday declined to take up Amgen Inc's bid to rei...
Read more »

Amgen CEO on cholesterol drug price cut: 'Too many patients' were struggling to payAmgen CEO on cholesterol drug price cut: 'Too many patients' were struggling to payJim Cramer sits down with Amgen Chairman and CEO Bob Bradway to hear about the company's recent price cut for one of its key drugs.
Read more »

House Democrats launch drug-pricing probe into a dozen major health-care companiesHouse Democrats launch drug-pricing probe into a dozen major health-care companiesAbbVie, Amgen, AstraZeneca, Celgene, Eli Lilly, Johnson & Johnson, Mallinckrodt, Novartis, Novo Nordisk, Pfizer, Sanofi and Teva Pharmaceuticals received letters seeking detailed information and documents about the companies' pricing practices.
Read more »

U.S. lawmaker launches investigation into pharma drug pricingU.S. lawmaker launches investigation into pharma drug pricingRepresentative Elijah Cummings, who chairs the House Oversight Committee, sent letters to 12 drugmakers seeking information on price increases, investment in research and development, and corporate strategies to preserve market share and pricing power, his office said in a statement. Novo Nordisk, Amgen
Read more »

A Big, Fatty Opportunity for Big PharmaA Big, Fatty Opportunity for Big PharmaThe next multibillion-dollar therapeutic area for drug companies may be fatty liver disease, but there are a few practical hurdles to overcome first.
Read more »

U.S. top court rejects Amgen over cholesterol medication patent fightU.S. top court rejects Amgen over cholesterol medication patent fightThe U.S. Supreme Court on Monday declined to take up Amgen Inc's bid to rei...
Read more »

Box Office: 'Aquaman' Just Topped $1 Billion, And Here's A Big Reason WhyBox Office: 'Aquaman' Just Topped $1 Billion, And Here's A Big Reason WhyLike 'Wonder Woman' and 'Black Panther,' 'Aquaman' is a huge hit partially because it's the first movie starring that specific superhero.
Read more »

Box Office: 'Aquaman' Just Topped $1 Billion, And Here's A Big Reason WhyBox Office: 'Aquaman' Just Topped $1 Billion, And Here's A Big Reason WhyLike 'Wonder Woman' and 'Black Panther,' 'Aquaman' is a huge hit partially because it's the first movie starring that specific superhero.
Read more »



Render Time: 2025-03-07 02:10:26